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Abstract
Background
In most high HIV burden countries, many HIV patients do not have reliable access to
required diagnostic laboratory tests. Task shifting of clinical tasks to lower cadres of health
care workers and lay counselors has been successful in scaling up treatment for HIV and
may also be an effective strategy in expanding access to essential diagnostic testing.
Methods
We screened major electronic databases between 1 January 2005 to 26 August 2018 to
identify studies assessing ease of use and accuracy of task shifting of HIV-related diagnos-
tic testing and/or specimen collection to non-laboratory health staff. Two independent
reviewers screened all titles and abstracts for studies that analyzed diagnostic accuracy,
patient impact, ease-of-use, or cost-effectiveness. Studies were assessed for quality, bias,
and applicability following the QUADAS-2 framework. We generated summary estimates
using random-effects meta-analyses.
Results
We identified 42 relevant studies. Overall, point-of-care CD4 testing performed by non-labo-
ratory staff had a mean bias of -54.44 (95% CI: -72.40 –-36.48) compared to conventional
laboratory-based. Though studies were limited, the diagnostic accuracy of point-of-care ala-
nine transaminase enzyme (ALT) and hemoglobin testing performed by non-laboratory staff
was comparable to conventional laboratory-based testing by laboratory professionals.
Point-of-care testing and/or specimen collection were generally found to be acceptable and
easy to use for non-laboratory staff.
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Conclusions
Task shifting of testing using point-of-care technologies to non-laboratory staff was compa-
rable to laboratory professionals operating the same technology in the laboratory. Some var-
iability was observed comparing the performance of point-of-care CD4 testing by non-
laboratory staff to conventional laboratory-based technologies by laboratory professionals
indicating potential lower performance was likely technological rather than operator caused.
The benefits of task shifting of testing may outweigh any possible harms as task shifting
allows for increased decentralization, access of specific diagnostics, and faster result
delivery.
Background
In most high HIV burden countries in sub-Saharan Africa, many HIV patients currently do
not have reliable access to required diagnostic laboratory tests. This is in part because these
countries have limited health human resource capacity, including laboratory professionals.
The successful scale up and management of antiretroviral therapy in Africa and other low- and
middle-income settings has depended critically on a public health approach that relies on
decentralization of treatment to primary health care facilities and lesser-trained health workers
in primary care services to deliver HIV testing and antiretroviral therapy to the majority of
HIV positive patients [1]. This approach has supported the delivery of HIV testing and antire-
troviral therapy at scale in resource-limited settings: of the estimated 19.4 million people with
HIV receiving antiretroviral therapy, nearly 14 million are living in Africa [2,3]. Providing
greater access to antiretroviral therapy and diagnostic testing are critical to achieve UNAIDS
90-90-90 targets by 2020 [4].
Task shifting describes the process of capacitating lesser-trained health workers to provide
specific services previously delivered by specialists with higher levels of training. The severe
shortage of health care workers including doctors, nurses, and laboratory professionals in high
HIV burden countries led a number of countries in sub-Saharan Africa to pioneer task shifting
and allow lay providers to conduct HIV rapid testing and nurses to deliver antiretroviral ther-
apy, significantly expanding access to services [5–8]. Lay provider HIV testing was recom-
mended in the 2015 WHO consolidated guidelines on HIV testing services following a
systematic review of the evidence demonstrating non-inferiority [6,7,9]. Furthermore, nurse-
led antiretroviral therapy delivery was endorsed by the World Health Organization in 2007
[8], with safety and efficacy subsequently validated through randomized trials since 2010 [10].
With increasing numbers of patients tested and on antiretroviral therapy, greater access to
laboratory monitoring will be required to optimize treatment, prevent adverse outcomes, and
reduce onward transmission. The lack of skilled laboratory professionals at health care facili-
ties, particularly in rural settings, may similarly justify task shifting of diagnostic testing and
specimen collection to lower cadres of health care workers. Despite rapid scale up of antiretro-
viral therapy services many countries face difficulties in diagnosing opportunistic infections
and monitoring treatment safety and effectiveness due to a shortage of laboratory professionals
and other skilled health workers to collect the specimens and conduct testing [11]. While
WHO guidelines for the management of HIV infection have promoted an approach that relies
on limited laboratory tests, there remains a need to ensure that a minimum set of tests are
available to diagnose severe opportunistic infections and to monitor treatment safety and
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effectiveness [12]. A number of existing diagnostic technologies have been developed that can
be used outside of sophisticated and specialized laboratory systems and allow for greater
decentralization and wider access to diagnostic testing [13]. Rapid diagnostic tests for HIV
and syphilis diagnosis and liver function testing as well as point-of-care technologies for CD4,
HIV nucleic acid (viral load and early infant diagnosis), creatinine, and hemoglobin testing
exist, with more in development [13]. In several countries, lower cadre health workers have
been successfully trained to collect sputum and/or whole blood specimens and to conduct a
range of discrete laboratory tests, including HIV/syphilis rapid tests as well as CD4 cell count
measurements, TB, malaria, chemistry, liver function and hematology assays [14–55].
We undertook this systematic review in order to summarize the available evidence on task
shifting of specimen collection and performing common laboratory tests using point-of-care
technologies as part of monitoring routine HIV care and treatment.
Methods
Search strategy and study selection
This review was carried out according to the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) [56]. The protocol was reviewed and approved by WHO.
PubMed, Medline and EMBASE databases were searched from 1 January 2005 to 26 August
2018 in parallel to identify peer-reviewed original research. An initial search was performed on
April 23rd, 2015 and an updated search on August 27th, 2018 –search terms were the same and
the results combined. Search terms were developed using the MeSH term formats as follows:
HIV-positive patients (population), non-laboratory professionals (operators), task shifting
(intervention), and outcomes (accuracy, retention, cost-effectiveness, and acceptability) (S1
Fig). Conference abstracts within the search dates from the Conference on Retroviruses and
Opportunistic Infections (CROI), International Conference on AIDS and STIs in Africa
(ICASA), International AIDS Society (IAS), and AIDS Conference and bibliographies were
also screened and reviewed for possible inclusion. Two reviewers (LV, CB, JM, LH) working
independently screened all titles and abstracts for eligibility. Studies were included if they com-
pared the diagnostic accuracy, patient impact, acceptability, or cost-effectiveness of non-labo-
ratory staff performing HIV-related diagnostic testing and/or specimen collection compared
to laboratory professionals. Bibliographies of all included studies were also reviewed to identify
unpublished, non-peer reviewed work for possible inclusion. Non-English studies were
excluded. Data were extracted from each included study including sample size, sample type,
test setting, end-user cadre, comparator, study dates, and outcomes of diagnostic accuracy
metrics and acceptability. Studies were assessed for quality, bias and applicability following the
QUADAS-2 quality appraisal tool [57].
Data analysis
The primary outcome of interest was the diagnostic accuracy of non-laboratory staff in per-
forming the specimen collection and/or diagnostic test compared to laboratory professionals.
In particular, bias and sensitivity/specificity were sought. Secondary outcomes included timing
and retention of patients along the cascade of care, cost-effectiveness, and acceptability of test-
ing or specimen collection when performed by non-laboratory staff compared to laboratory
professionals. To determine the presence of between-study heterogeneity, the I-squared statis-
tic was calculated [58]. When at least four studies exist, random effects models were used to
estimate the pooled summary measures for diagnostic accuracy: the metaprop (for propor-
tions) and metan (for continuous values) were used in Stata with a continuity correction value
of 0.5 and exact confidence intervals.
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Two reviewers (LV, CB/JM) independently performed the statistical analysis to ensure
accuracy. Graphic representations were completed in GraphPad Prism v6.0 (La Jolla, Califor-
nia, USA) and analyses were completed in Stata 13 (College Station, Texas, USA).
Results
Study characteristics
Of 12,842 titles screened, 42 eligible studies were included for review (Fig 1) [14–55]. Approxi-
mately 13,686 data points were included in the diagnostic accuracy analysis and 43 different
analyses. The included studies spanned 20 countries (Table 1). Most studies (86%) were car-
ried out in Africa, three were performed in Brazil, and one each in Vietnam and China. Testing
and specimen collection were performed at a mix of health care facilities: urban hospitals,
urban clinics, urban outreach, remote hospitals, and rural clinics. Ten different point-of-care
test types with 14 different technology assays were included performed by 11 non-laboratory
health care cadres (Table 2); five studies analyzed specimen collection. Sixty-four percent of
studies looked at POC CD4 with 85% of those studies reviewing the accuracy of the Alere
Pima technology. Nurses were included as index test end-users in 60% of studies. All studies
were observational or diagnostic accuracy studies, except for one randomized controlled trial
and one meta-analysis. Studies were conducted between 2006 and 2018.
Overall, there was moderate risk of bias across the studies (S2 Fig). Patient, health care
facility, and health care cadre inclusion and exclusion criteria were unclear or not stated in
several studies. Studies often had variable study objectives and test types making compari-
sons across studies difficult. Only four diagnostic accuracy studies directly compared the
technical performance of the point-of-care technology between non-laboratory staff and lab-
oratory professionals. Twenty-six studies compared the accuracy of point-of-care CD4 test-
ing performed by non-laboratory staff to laboratory CD4 assays performed by laboratory
staff.
Diagnostic accuracy of point-of-care testing performed by non-laboratory
staff
The primary outcome observed across the majority of studies focused on the diagnostic accu-
racy performance of point-of-care testing when performed by non-laboratory staff. The mean
bias measurement was most often included across studies [19–21,25,26,28,31,32,34,36,37,39,
41–43,45,55]. Compared to conventional laboratory-based testing performed by laboratory
professionals, point-of-care CD4 testing performed by non-laboratory staff had a mean bias of
-54.44 (95% CI: -72.40 –-36.48) (I2: 17.6%, p = 0.212) (Fig 2a). Sixty-five percent (17/26) of
studies had a mean bias within a +/- 50 cells/ul range. Only four studies compared the
performance of point-of-care CD4 testing between laboratory professionals and non-labora-
tory staff [17,28,41,55]. The performance of each study was similarly within the +/-50 cells/ul
range and the overall mean bias was -13.34 (95% CI: -19.98 –-6.69) (I2: 0.0%, p = 0.502)
(Fig 2b). In one study, conventional laboratory-based testing performed by laboratory profes-
sionals had a coefficient of variation of approximately 7.5%, while the point-of-care CD4
technology performed by non-laboratory staff, nurses, had a coefficient of variation of
approximately 10.7% [28]. The sensitivity and specificity of identifying patients in need of
treatment based on the relevant CD4 count used at the time of the study was also calculated
from relevant studies (Fig 2c and 2d). The estimated sensitivity and specificity were 95%
(95% CI: 92–97%) (I2: 68.9%, p = 0.000) and 82% (95% CI: 76–89%) (I2: 95.6%, p = 0.000),
respectively.
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Two studies reviewed the performance of cryptococcal antigen lateral flow assays when
used by non-laboratory staff [53,54]. The sensitivity and specificity of non-laboratory staff cor-
rectly identifying cryptococcal antigen were 100% in both studies. Additionally, syphilis testing
by non-laboratory staff using the dual HIV/syphilis rapid diagnostic test had an agreement of
0.666 (0.358–0.974) and a specificity of 99.9% (95% CI: 99.8–100%) compared to when
Fig 1. PRISMA flow chart.
https://doi.org/10.1371/journal.pone.0216277.g001
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Table 1. Study characteristics of included studies in meta-analysis.
Author Ref
#
Journal Year Countries of
study
Type of study Years of
study
Site type Test Technology Sample type Comparator
Agizew [14] PLoS One 2017 Botswana step-wedged
clinical trial
2012–2014 HIV C&T sites POC TB/RIF Xpert MTB/RIF Sputum Xpert MTB/RIF
Arnett [15] IAS poster 2013 Tanzania technical
evaluation
unknown clinics POC CD4 Alere Pima unknown Pima in lab
finger-prick
capillary
laboratory CD4
finger-prick
capillary
microtube
laboratory CD4
venous laboratory CD4
Benzaken [16] STI 2014 Brazil prospective
observational
2010–2011 remote clinics syphilis TR Syphilis
3.0-SD Bioline
DTS (6 each) known results
Bile [17] CROI poster 2017 Bostwana randomised
controlled trial
2013–2016 mobile and home
testing
POC CD4 Alere Pima unknown laboratory Alere
Pima
Brouillette [18] IAS poster 2013 Uganda retrospective
observational
2011–2012 clinics POC CD4 Alere Pima
Bwana [19] PLoS One 2015 Kenya prospective
observational
2014–2015 rural clinics, sub-
district hospital
POC CD4 BD FACS Presto finger-prick
capillary
BD FACS Presto
BD FACS Count
BD FACS Calibur
Alere Pima
Daneau [20] PLoS One 2016 Tanzania prospective
observational
2014 urban clinics POC CD4 BD FACS Presto finger-prick
capillary
BD FACSCalibur
venous blood
Diaw [21] JAIDS 2011 Senegal technical
evaluation
2009–2010 urban clinics POC CD4 Alere Pima finger-prick
capillary
BD FACSCount
Fajardo [22] Bulletin
WHO
2015 9 sSA retrospective
observational
2011–2013 primary and
mobile clinics,
community
POC CD4 Alere Pima NA
Garone [23] AIDS conf 2014 Malawi prospective
observational
2013–2014 primary clinic viral load dried blood spot finger-prick
capillary
NA
Gimbel-
Sherr
[24] HRH 2007 Mozambique retrospective
operational
2004–2005 urban clinics POC CD4 not indicated unknown
Glencross [25] JIAS 2012 South Africa technical
evaluation
unknown urban hospital POC CD4 Alere Pima finger-prick
capillary
Beckman Coulter
PLGurban clinic
Gous [26] PLoS One 2013 South Africa technical
evaluation
2012 urban hospital POC CD4 Alere Pima finger-prick
capillary
Beckman Coulter
PLG
Hemoglobin HemoCue
Hb201+
Advia 120, 2120
ALT Roche Reflotron
Plus
Synchron DXC
800
Cr Roche Reflotron
Plus
Synchron DXC
800
Gous [27] JAIDS 2016 South Africa prospective
observational
2010–2012 urban clinics POC CD4 Alere Pima venous blood /
venidrop
Beckman Coulter
Hemoglobin HemoCue
Hb201+
Advia 120 and
2120
ALT Roche Reflotron
Plus
Advia 1800 and
Synchron DXC
801
Creatinine Roche Reflotron
Plus
Advia 1800 and
Synchron DXC
804
Lactate Accutrend Advia 1800
Jani [28] AIDS 2011 Mozambique technical
evaluation
2009–2010 urban clinics POC CD4 Alere Pima finger-prick
capillary
BD FACSCalibur
POC CD4 Alere Pima Alere Pima in lab
ALT Roche Reflotron
Plus
Selectra Junior
AST Roche Reflotron
Plus
Selectra Junior
Hemoglobin HemoCue
Hb201+
Sysmex SF3000
(Continued)
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Table 1. (Continued)
Author Ref
#
Journal Year Countries of
study
Type of study Years of
study
Site type Test Technology Sample type Comparator
Jani [29] AIDS 2016 Mozambique retrospective
observational
2012–2013 clinics POC CD4 Alere Pima finger-prick
capillary
NA
Kaindjee-
Tjituka
[30] Afr J Lab Med 2017 Namibia prospective
observational
2011 public clinics POC CD4 Alere Pima finger-prick
capillary
NA
Kohatsu [31] PLoS One 2018 Tanzania prospective
observational
2011 urban clinics POC CD4 Alere Pima finger-prick
capillary direct
drop
BD FACSCalibur
finger-prick
capillary
microtube
venous blood
Lassovski [32] poster 2013 Swaziland retrospective
observational
2010–2012 rural/urban clinics POC CD4 Alere Pima controls NA
creatinine Roche Reflotron
Plus
glucose Roche Reflotron
Plus
potassium Roche Reflotron
Plus
ALAT Roche Reflotron
Plus
Liang [33] Chin Med J 2015 China prospective
observational
2012 urban clinics POC CD4 Alere Pima finger-prick
capillary
BD FACSCalibur
venous blood
MacLennan [34] AIDS 2007 Malawi technical
evaluation
2006 urban clinic POC CD4 BD
FACSCalibur
finger-prick
capillary
venous
FACSCalibur
Maiers [35] 2014 South Africa prospective
observational
urban clinic blood collection
of 150ul
finger-prick
capillary
Manabe [36] PLoS One 2012 Uganda technical
evaluation
2009 urban hospital POC CD4 Alere Pima finger-prick
capillary
Morawski [37] JAIDS 2013 Uganda technical
evaluation
urban clinics POC CD4 Alere Pima venous blood BD FACSCalibur
Mwanja [40] IAS poster 2013 Tanzania retrospective
observational
2011–2012 clinics POC CD4 Alere Pima finger-prick
capillary
Mwau [41] PLoS One 2014 Kenya technical
evaluation
2014 rural clinics POC CD4 Zyomyx MyT4 finger-prick
capillary
BD FACSCount
Zyomyx in lab
Myer [42] JIAS 2013 South Africa technical
evaluation
unknown urban clinic POC CD4 Alere Pima venous blood laboratory assay
Negedu-
Momoh
[43] PLoS One 2017 Nigeria prospective
observational
2015–2016 rural hospital
clinic
POC CD4 BD FACSPresto finger-prick
capillary
BD FACSCalibur
Olugbenga [44] PLoS One 2018 Nigeria prospective
observational
antenatal clinics HIV/Syphilis SD BIOLINE
HIV/Syphilis
finger-prick
capillary
SD BIOLINE HIV/
Syphilis in lab
TPHA Lab
Pinto [45] PLoS One 2015 Brazil prospective
observational
2013–2014 rural clinics POC CD4 Alere Pima finger-prick
capillary
BD FACSCalibur
venous blood
Pollock [46] PLoS One 2013 Vietnam urban clinic ALT Diagnostics for
All
finger-prick
capillary
Roche Cobas ALT
Riberio [47] STI 2014 Brazil prospective
observational
2011–2012 urban outreach syphilis SD Bioline
Syphilis 3.0
DTS (4 each) known results
Rutstein [48] JCV 2014 Malawi technical
evaluation
unknown remote hospitals viral load dried blood spot finger-prick
capillary
NA
Sangala [49] IJTLD 2006 Malawi qualitative unknown rural clinics,
district hospital
tuberculosis sputum
collection
sputum NA
Scott [50] BMC 2015 global pooled data
meta-analysis
2009–2014 various CD4 Alere Pima finger-prick
capillary
conventional CD4
Simmonds [51] IAS poster 2018 Zimbabwe retrospective
observational
2016–2017 POC EID Alere q HIV 1/2
Detect
heel-prick
capllary
NA
(Continued)
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compared to laboratory technicians [44]. Furthermore, nursing staff successfully tested exter-
nal quality assurance panels using syphilis rapid tests with a sensitivity and specificity over
90% [16,47].
Three studies compared the performance of alanine aminotransferase (ALT) and hemoglo-
bin enumeration tests operated by non-laboratory staff with conventional laboratory-based
technologies operated by laboratory professionals [26–28]. Non-laboratory staff operated both
tests comparably to conventional laboratory-based technologies operated by laboratory profes-
sionals (Fig 3a and 3b). A semi-quantitative, visual point-of-care ALT assay performed by
nurses had a sensitivity and specificity of 87% and 77%, respectively, compared to a
Table 1. (Continued)
Author Ref
#
Journal Year Countries of
study
Type of study Years of
study
Site type Test Technology Sample type Comparator
Tsibolane [62] unpublished 2014 South Africa retrospective
observational
2014 urban/rural clinics POC CD4 Alere Pima finger-prick
capillary
NA
Wake [63] JAIDS 2018 South Africa prospective
observational
2016–2018 HIV clinics POC CrAg CrAg LFA finger-prick
capillary
POC CrAG
Williams [54] Clin Infect
Dis
2015 Uganda prospective
observational
2013–2014 POC CrAg CrAg LFA finger-prick
capillary
POC CrAG
Zeh [55] J Immunol
Methods
2017 Kenya prospective
observational
unknown rural hospital
clinic
POC CD4 Alere Pima finger-prick
capillary
BD FACSCalibur
venous blood BD FACSCalibur
finger-prick
capillary
Alere Pima in lab
Zinyowera [38] unpublished Zimbabwe prospective
observational
unknown central POC viral
load
SAMBA II proficiency
panel
known results
Zinyowera [39] JAIDS 2010 Zimbabwe technical
evaluation
unknown urban clinic POC CD4 Alere Pima finger-prick
capillary
BD FACSCalibur
C&T: care and treatment
ALT: alanine aminotransferase
AST: aspartate aminotransferase
DTS: dried tube specimens
Known results: proficiency panels with already known results
https://doi.org/10.1371/journal.pone.0216277.t001
Table 2. Test types, technologies used, and non-laboratory health care cadres in included studies.
Test types and technologies used Non-laboratory health care cadres
CD4: Alere Pima (device), Zyomyx MyT4 (device), BD FACSPresto
(device)
Nurses (25 studies): staff, technicians,
assistants, practitioners
Syphilis: SD Bioline (lateral flow) Physicians (2)
HIV nucleic acid: dried blood spot (specimen), SAMBA II (device),
Alere q HIV 1/2 Detect (device)
Health surveillance assistants (2)
ALT: Roche Reflotron Plus (device), Diagnostics for All (lateral flow) ANC provider (2)
AST: Roche Reflotron Plus (device) Clinic staff (7)
Hemoglobin: HemoCue Hb201+ (device) Laypersons (1)
Creatinine, glucose, potassium: Roche Reflotron Plus (device) Lay counsellors (6)
Tuberculosis: sputum collection (specimen), Cepheid GeneXpert
MTB/Rif (device)
Biologists (2)
Cryptococcal antigen: IMMY CrAg LFA (lateral flow) Microscopists (2)
Lactate: Accutrend (device) VCT staff (1)
Phlebotomist (1)
https://doi.org/10.1371/journal.pone.0216277.t002
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conventional laboratory-based technology operated by laboratory professionals [46]. Finally,
one study reviewed the performance of creatinine and lactate testing by non-laboratory staff at
two separate clinics [27]. Creatinine testing had mean bias values of -4.5 umol/L (95% CI:
-2.09 –-6.42) and -5.5 umol/L (95% CI: -4.49 –-6.42), while lactate testing had mean bias values
of 0.01 mmol/L (95% CI: -0.1–0.13) and 1.1 mmol/L (95% CI: 1.04–1.18).
Quality of testing
We further sought to understand the proportion of test errors (device and operator) encoun-
tered when technologies were used and specimens collected by non-laboratory staff. Only
error rates from point-of-care CD4 technologies were reported in the included studies
[15,20,21,25,30,36,40–42]. The proportion of error rates across studies for point-of-care CD4
was 12% (95% CI: 9–14%) (Fig 4). Unfortunately, error rates for conventional laboratory-
Fig 2. Forest plots of point-of-care CD4 diagnostic accuracy performance by non-laboratory staff. (a) point-of-care CD4 testing by non-laboratory
staff compared to conventional laboratory-based testing by professional laboratory staff; (b) point-of-care CD4 testing by non-laboratory staff
compared to point-of-care CD4 testing by professional laboratory staff; the shaded box represents +/- 50 cells/ul in (a) and (b). (c) sensitivity of
correctly classifying patients below a CD4 threshold of 350 cells/ul; (d) specificity of correctly classifying patients above a CD4 threshold of 350 cells/ul.
https://doi.org/10.1371/journal.pone.0216277.g002
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based technologies operated by laboratory professionals were not included in any study, pre-
venting comparison; however, the proportion of point-of-care CD4 errors was below 10% for
two of the three studies where programmatic, routine point-of-care CD4 testing was per-
formed [22,29,52]. The remaining nine studies reported point-of-care CD4 error rates from
diagnostic accuracy evaluations and had significantly smaller sample sizes. Furthermore, addi-
tional studies found error rates using the Cepheid Xpert MTB/RIF were 17% (95% CI: 11–
25%) and Alere q Detect early infant diagnosis were 9.24% when operated by non-laboratory
staff [14,51].
Acceptability of testing by non-laboratory staff
Eight studies assessed the acceptability and ease-of-use for testing operated by non-laboratory
staff [15,16,23,24,30,35,38,49]. The measures of acceptability were heterogenous making
Fig 3. Forest plots of point-of-care ALT and hemoglobin diagnostic accuracy performance by non-laboratory staff. (a) point-of-care ALT testing
by non-laboratory staff compared to conventional laboratory-based testing by professional laboratory staff; (b) point-of-care hemoglobin testing by
non-laboratory staff compared to conventional laboratory-based testing by professional laboratory staff.
https://doi.org/10.1371/journal.pone.0216277.g003
Fig 4. Error rates for point-of-care CD4 technologies operated by non-laboratory staff. Red forest plot and line
indicate the overall pooled error rate. Blue forest plots indicate studies focused on program-wide, routine testing.
https://doi.org/10.1371/journal.pone.0216277.g004
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summary statistics challenging. One study observed an ease-of-use score for task-shifting
point-of-care CD4 testing between 1.7–3 using a scale of 1–5 (5 being very difficult) and health
care worker trust in the test was measured at between 82–100% [15]. Another study found an
odds ratio of 1.9 (1.1–3.3) for more rational use of higher-level clinical staff time with the
introduction of point-of-care CD4 testing operated by lower-level staff instead [24]. Further-
more, 94.7% (95% CI: 92.9–95.9%) of lay health workers rated the point-of-care CD4 technol-
ogy favorably [30]. Point-of-care viral load testing was found to be easy, or very easy, to use by
all non-laboratory staff, while 85% of questionnaire respondents indicated that point-of-care
viral load testing was suitable or very suitable for non-laboratory staff [38]. Ninety percent of
non-laboratory staff identified that a syphilis rapid diagnostic test was easy to use [16], while
antenatal care staff scored the dual HIV/syphilis rapid diagnostic test 2.41 (out of 3) for ease of
use and 2.27 (out of 3) for ease of interpretation [44].
Acceptability specimen collection by non-laboratory staff
Additionally, 58% of non-laboratory staff indicated that preparing dried blood spot specimens
for viral load was very easy, while 43% indicated that the specimen collection was easy [23].
Eighty-five percent of respondents indicated that dried blood spot preparation was suitable for
non-laboratory staff. A 98% success rate of finger-prick blood specimen collection by nurses
was observed in South Africa [35]. Finally, one study found that sputum collection in ANC
wards for tuberculosis testing was acceptable, but there were some concerns over staff avail-
ability, waiting times, and overload [49].
Discussion
This review provides evidence of the ease-of-use, acceptability, and accuracy of task shifting to
support access to specific laboratory tests in HIV programs. The introduction of point-of-care
technologies as well as easy to use and/or stable specimen collection technologies, such as
dried blood spot filter paper, accordingly allow for task shifting and decentralization of these
clinical tasks. This review found that non-laboratory staff operated point-of-care testing com-
parably to laboratory professionals operating the same point-of-care test in the laboratory
(mean bias +/-<15 cells/ul). Some variability, however, was observed comparing the perfor-
mance of point-of-care CD4 testing by non-laboratory staff to conventional laboratory-based
technologies by laboratory professionals (mean bias +/-< 55 cells/ul). These results are consis-
tent with the fact that test variability can be expected even within the same technology and
health care cadre; however, indicative that weaker performance may have been caused by the
technology rather than the health care worker cadre performing the testing. Comparable per-
formance was also seen with syphilis, cryptococcal diagnosis as well as ALT and hemoglobin
testing, though the number of studies and sample sizes were small for each.
WHO recently recommended task shifting of HIV testing services to lay counselors [9], fol-
lowing a systematic review which found that uptake of testing doubled with task shifting of
testing to lay counselors as well as comparable performance between lay counselors and labo-
ratory staff in terms of accurate diagnoses [6,7]. Furthermore, this review found high patient
satisfaction of HIV testing experiences when tested by lay counselors. Similarly, studies and
guidelines have been published confirming the utility, impact, and non-inferiority of task shift-
ing to deliver antiretroviral therapy [1,5,8], while this review provides and adds a diagnostic
viewpoint. This systematic review highlights that task shifting for other laboratory tests is likely
to be comparably valuable for increased patient access and decentralization. Additionally,
health care facility staff and patient familiarity with task shifting of HIV rapid testing and same
day test result delivery should allow for faster uptake of wider diagnostic task shifting.
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Several studies reviewed the acceptability and ease-of-use of point-of-care technologies and
specimen collection from the perspective of non-laboratory staff. All found that point-of-care
testing and specimen collection were easy to perform and acceptable for non-laboratory staff.
Furthermore, the acceptability of task shifting from the perspective of health workers is evi-
denced by widespread implementation of point-of-care testing and specimen collection per-
formed by non-laboratory staff [59,60]. Dried blood spot sample collection for early infant
diagnosis, for example, has been significantly decentralized and task-shifted to non-laboratory
staff across sub-Saharan Africa and Southeast Asia [59,61,62]. A recent systematic review
reported that within 12 studies, 90% of patients accepted point-of-care CD4 testing in primary
health care and community settings [63].
Diagnostic assays have differing complexity and may vary in their suitability and potential
placement based on health care facility infrastructure, human resource capacity, result inter-
pretation, device and third-party equipment requirements, and reagent stability [13]. For
example, rapid diagnostic tests or lateral flow assays generally do not require cold storage of
reagents, electricity, specialized laboratory skills such as precise measurements using a pipet,
daily calibration of devices, or centrifugation of specimens. Alternatively, there are device-
based technologies that require some electricity, while others may require consistent electric-
ity, temperature controlled rooms, precise measurements of specimens or reagents, or even
plasma separation of whole blood using third-party procured centrifuges. Such technology
characteristics and requirements may limit decentralization, the extent of task shifting, and
thus patient access to testing.
While this review focused on HIV-related tests and specimen collection, the same princi-
ples, impact, and benefits, will likely apply beyond HIV programs. Task shifting of syphilis,
hemoglobin, malaria, and/or hepatitis testing in antenatal facilities, for example, using rapid or
point-of-care technologies by midwives could significantly expand access to these critical diag-
nostics. Additional tests, specimens, and program areas should be considered for task shifting
as is feasible and beneficial, primarily to the patients and clinical delivery of optimal care.
As with task shifting of HIV treatment, the success of laboratory task shifting for supporting
HIV care will rely on careful and transparent test and product selection processes, training,
and quality monitoring and mentorship. Understanding patient volumes, testing needs, and
health care facilities’ characteristics, such as available infrastructure and human resource
capacity, will allow for appropriate selection of testing technologies that best fit each health
care facility. Significant decentralization of any service, including task shifting of testing, will
require careful training of health care facility staff prior to implementation. Furthermore, this
approach should be supported by national policy, and this should stipulate the need for ade-
quate training and supervision. Continuous monitoring and mentorship will ensure that chal-
lenges and corrective actions are quickly and appropriately managed. Ensuring these processes
are implemented with task shifting into the national testing policies will support improved
access to quality diagnostic testing and clinical patient management.
This review has several limitations. Most studies compared the point-of-care technology
operated by non-laboratory staff with a conventional laboratory-based technology operated by
laboratory professionals. The data generated thus far suggest task shifting specimen collection
and point-of-care testing to non-laboratory staff provides comparable performance to labora-
tory professionals; however, additional studies with direct comparisons would be beneficial to
further support the conclusions. Additionally, few studies looked at the diagnostic accuracy of
task-shifting with other (non-CD4) test types and while some trends can be drawn, the conclu-
sions would benefit from additional work, including other and new assays such as hepatitis C,
hepatitis B core antigen, and human papillovirus. Further, as our review looked at all non-HIV
rapid testing task-shifting, most studies focused on device-based assays. Comparisons between
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non-HIV testing laternal flow assays and device-based assays could not be made. Furthermore,
search terms and engines may not have been exhaustive and could have missed studies eligible
for inclusion. While retrospective studies provided compelling evidence, only one randomized
control trials was included in the systematic review. Included studies had variable study objec-
tives, different test types utilized, and various health care cadres, making comparisons and a
meta-analysis difficult. Furthermore, most diagnostic accuracy studies had small sample sizes
and, therefore, correspondingly wide confidence intervals that prevented strong conclusions.
Finally, whilst it is critical to understand that diagnostic accuracy does not suffer with task
shifting to non-laboratory staff, a primary objective of task shifting is to provide great access to
faster test results, better overall quality care, and a more efficient system. However, no studies
provided data on the timing and retention of patients along the cascade of care or cost-effec-
tiveness of task-shifting specimen collection and/or testing.
Additional studies to more carefully determine the cause of diagnostic accuracy variability
would be useful. For example, the level of variability expected within and between technolo-
gies. Furthermore, while studies have observed significant patient impact when implementing
point-of-care CD4 technologies [64], it would be useful to better understand and weigh the
benefits and harms of decentralization and task shifting with possible loss in testing quality, if
observed.
An expert panel considered the findings of this review during the revision of the 2016
WHO guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.
These updated guidelines recommend, as good practice, that trained supervised non-labora-
tory staff, including laypersons, can undertake blood finger prick for sample collection [12].
Incorporating task shifting for diagnostic testing and specimen collection into national policy
will allow for greater decentralization and increased access of testing services as well as further
support decentralized antiretroviral therapy management.
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